New Concept to Boost Energy and Power Peformance of Practical Electrochemical Devices

International audienc

In situ redox functionalization of composite electrodes for high power-high energy electrochemical storage systems via a non-covalent approach

The growing demand for new global resources of clean and sustainable energy emerges as the greatest challenge in today\u27s society. For numerous applications such as hybrid vehicles, electrochemical storage systems simultaneously require high energy and high power. For this reason, intensive researches focus on proposing alternative devices to conventional Li battery and supercapacitors. Here, we report a proof of concept based on non-covalent redox functionalization of composite electrodes that may occur either during the calendar life or during the device functioning. The active material, a multi-redox pyrene derivative, is initially contained in the electrolyte. No additional benchmarking step is therefore required, and it can, in principle, be readily applied to any type of composite electrode (supercapacitors, battery, semi-solid flow cell etc.). Accordingly, a practical carbon fiber electrode that is 10 mg cm(-2) loaded can deliver up to 130 kW kg(electrode)(-1) and 130 Wh kg(electrode)(-1) with negligible capacity loss over the first 60 000 charge/discharge cycles

New concept and electrochemistry of in situ non-covalent immobilization of redox molecules for energy storage applications

International audienc

Improved electro-grafting of nitropyrene onto onion-like carbon via in situ electrochemical reduction and polymerization: tailoring redox energy density of the supercapacitor positive electrode

Herein, we report a improved method for the physical grafting of 1-nitropyrene (Pyr-NO2) onto highly graphitized carbon onion. This is achieved through a lowering of the onset potential of the pyrene polymerization via in situ reduction of the NO2 group. The additional redox activity pertaining to the reduced NO2 enables exceeding the faradaic capacity which is associated with the p-doping of the grafted pyrene backbone, as observed for pyrene, 1-aminopyrene, and unreduced Pyr-NO2. Theoretical calculations demonstrate the charge transfer and binding enthalpy capabilities of Pyr-NO2, which are significantly higher than those of the other two species, and which allow for improved p-stacking on the carbon surface. Upon 20 wt % grafting of Pyr-NO2, the capacity of the electrode jumps from 20 mAh g-1 electrode to 38 mAh g-1 electrode, which corresponds to 110 mAh g-1 per mass of Pyr-NO2 and the average potential is increased by 200 mV. Very interestingly, this high performance is also coupled with outstanding retention with respect to both the initial capacity for more than 4000 cycles, as well as the power characteristics, demonstrating the considerable advantages of employing the present in situ grafting technique

Composite Electrodes for Electrochemical Supercapacitors

Manganese dioxide nanofibers with length ranged from 0.1 to 1 μm and a diameter of about 4–6 nm were prepared by a chemical precipitation method. Composite electrodes for electrochemical supercapacitors were fabricated by impregnation of the manganese dioxide nanofibers and multiwalled carbon nanotubes (MWCNT) into porous Ni plaque current collectors. Obtained composite electrodes, containing 85% of manganese dioxide and 15 mass% of MWCNT, as a conductive additive, with total mass loading of 7–15 mg cm−2, showed a capacitive behavior in 0.5-M Na2SO4 solutions. The decrease in stirring time during precipitation of the nanofibers resulted in reduced agglomeration and higher specific capacitance (SC). The highest SC of 185 F g−1 was obtained at a scan rate of 2 mV s−1 for mass loading of 7 mg cm−2. The SC decreased with increasing scan rate and increasing electrode mass

Associations between environmental factors and hospital admissions for sickle cell disease

Sickle cell disease (SCD) is an increasing global health burden. This inherited disease is characterised by a remarkable phenotypic heterogeneity, which can only partly be explained by genetic factors. Environmental factors are likely to play an important role but studies of their impact on disease severity are limited and their results are often inconsistent. This study investigated associations between a range of environmental factors and hospital admissions of young patients with SCD in London and in Paris between 2008 and 2012. Specific analyses were conducted for sub-groups of patients with different genotypes and for the main reasons of admissions. Generalized additive models and distributed lag non-linear models were used to assess the magnitude of the associations and to calculate relative risks. Some environmental factors significantly influence the numbers of hospital admissions of children with SCD, although the associations identified are complicated. Our study suggests that meteorological factors are more likely to be associated with hospital admissions for SCD than air pollutants. It confirms previous reports of risks associated with wind speed (RR: 1.06/SD [95% confidence interval (CI): 1.00-1.12]) and also with rainfall (RR: 1.06/SD [95%CI: 1.01-1.12]). Maximum atmospheric pressure was found to be a protective factor (RR: 0.93/SD [95%CI: 0.88-0.99]). Weak or no associations were found with temperature. Divergent associations were identified for different genotypes or reasons of admissions, which could partly explain the lack of consistency in earlier studies. Advice to patients with SCD usually includes avoiding a range of environmental conditions that are believed to trigger acute complications, including extreme temperatures and high altitudes. Scientific evidence to support such advice is limited and sometimes confusing. This study shows that environmental factors do explain some of the variations in rates of admission to hospital with acute symptoms in SCD, but the associations are complex, and likely to be specific to different environments and the individual's exposure to them. Furthermore, this study highlights the need for prospective studies with large numbers of patients and standardised protocols across Europe